Atria Investments Inc Sells 427 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Atria Investments Inc trimmed its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 6.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,842 shares of the company’s stock after selling 427 shares during the period. Atria Investments Inc’s holdings in U.S. Physical Therapy were worth $518,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in USPH. Copeland Capital Management LLC grew its stake in shares of U.S. Physical Therapy by 9.5% in the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after purchasing an additional 72,715 shares during the period. State Street Corp grew its stake in shares of U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after purchasing an additional 99,244 shares during the period. Southernsun Asset Management LLC grew its stake in shares of U.S. Physical Therapy by 10.5% in the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after purchasing an additional 52,062 shares during the period. Geode Capital Management LLC grew its stake in shares of U.S. Physical Therapy by 1.3% in the 3rd quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock valued at $29,040,000 after purchasing an additional 4,477 shares during the period. Finally, Bahl & Gaynor Inc. grew its stake in shares of U.S. Physical Therapy by 135.4% in the 4th quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company’s stock valued at $23,076,000 after purchasing an additional 149,622 shares during the period.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the firm’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. JMP Securities assumed coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective on the stock. StockNews.com downgraded U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Friday, February 28th. Barrington Research reduced their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a report on Friday, February 28th. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $100.00 to $115.00 in a report on Monday, December 16th. Finally, William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $111.50.

U.S. Physical Therapy Price Performance

USPH opened at $76.68 on Friday. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63. The company has a fifty day simple moving average of $86.17 and a 200 day simple moving average of $87.34. The stock has a market cap of $1.16 billion, a P/E ratio of 81.57, a P/E/G ratio of 3.54 and a beta of 1.51.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $180.45 million for the quarter, compared to analyst estimates of $173.10 million. On average, research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.35%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio is currently 97.83%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.